A recent study conducted by Harvard Medical School has shown that aspirin is potentially a tool to fight a certain type of mutation in colon cancer. About one-sixth of all colon cancers have this particular mutation, but patients who took aspirin lived longer then those that didn't. The study wasn't designed to test aspirin's affects on colon cancer, this hypothesis was discovered as a by-product of doing other research. More testing is needed to determine if aspirin actually does have an affect at battling this specific mutation.
Even though the study isn't a conclusive answer, the possibilities that it brings to the table are tremendous. If aspirin, which is one of the cheapest pharmaceutical drugs and readily available, can be used to fight cancer, the overall cost will decrease traumatically. This brings new hope to people who are struggling to afford their treatments, and if something as affordable as aspirin can help then it is a huge relief for everyone.
To read the complete article: Click Here